Automated Telehealth Diagnostics for Remote Parkinson Monitoring

Currently, there is limited access to movement disorder specialist centers for a significant
portion of the PD population. Treatment effectiveness is judged during office visits by
improvement of patient motor symptoms and quality of life. Clinicians evaluate patients by
having them perform specific motor tasks and rating the severity on a 0-4 scale. A major
limitation is that a single evaluation in a clinical setting may not accurately reflect
motor symptom fluctuations experienced over the course of a day, week, or month. Clinicians
currently lack effective, affordable medical devices that can be easily delivered to a
patient's home for monitoring symptoms on a more continuous basis as motor symptoms
typically change throughout the day. Kinesia HomeView provides a repeatable, automated
system clinicians can use to remotely monitor PD motor symptoms on a more continuous basis
in a patient's home. The investigators hypothesize use of the Kinesia HomeView system will
improve outcomes and decrease costs especially for patient populations in areas not in close
proximity to movement disorder specialists.

Inclusion Criteria:

- Individuals with self-reported clinically-confirmed diagnosis of idiopathic Parkinson
disease.

- Be fluent in English

- Willing and able to provide informed consent

Exclusion Criteria:

- Inability to carry out study activities

- Subjects with cognitive deficits that would prevent following instructions and
serious medical conditions that would compromise a subject's safety

- Subjects who have dementia, exhibited by those with a score less than 22 on the
Montreal Cognitive Assessment (MoCA)

- Subjects with deep brain stimulation (DBS)